Clinical Trial Update: The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. [Phase 4]

View source ↗

Summary

A Phase 4 single-arm biomarker development trial evaluating ketamine for non-psychotic unipolar major depression and bipolar depression has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder
• Major Depression
• Unipolar Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Major Depression, Bipolar I Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-03-15